RISEDRONATE SODIUM vs SKELID

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 20, 2026·How we rate

Possible drug interaction. RISEDRONATE SODIUM and SKELID are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	RISEDRONATE SODIUM	SKELID
Rating	56/100	70/100
Pharmacy pays	~$73.02 /30	—
Type	RX	RX
Active ingredient	RISEDRONATE SODIUM	TILUDRONATE DISODIUM
Manufacturer	Teva	Sanofi Aventis US
Dosage forms	Tablet, delayed release	Tablet
Drug class	Bisphosphonate	—
Boxed warning	None	None
Half-life	about 561 hours — roughly 23 days	—
Treats	Extramammary Paget Disease, Postmenopausal Osteoporosis	Extramammary Paget Disease

risedronate sodium skelid

Rating

56/100

70/100

Pharmacy pays

~$73.02 /30

—

Type

Active ingredient

RISEDRONATE SODIUM

TILUDRONATE DISODIUM

Manufacturer

Teva

Sanofi Aventis US

Dosage forms

Tablet, delayed release

Tablet

Drug class

Bisphosphonate

—

Boxed warning

None

Half-life

about 561 hours — roughly 23 days

—

Treats

Extramammary Paget Disease, Postmenopausal Osteoporosis

Extramammary Paget Disease

Frequently asked questions

Which is better-rated, Risedronate Sodium or Skelid?

By our independent rating, Skelid scores higher — 3.5 vs 2.8 out of 5 for Risedronate Sodium. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Risedronate Sodium and Skelid?

Risedronate Sodium contains Risedronate Sodium, while Skelid contains Tiludronate Disodium — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.